Patience David
Chief Financial Officer
Patience David has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.
On the most recent filing, Patience David is listed as Chief Financial Officer at TriSalus Life Sciences, Inc. Inside the rolling window, Patience David reported 2 open-market purchases totaling $32K in TLSI and no open-market sales. The largest disclosed transaction in the window is a purchase of 7,100 TLSI shares on May 15, 2026, worth $17K.
Companies traded
Other insiders at TLSI
Insider Buying
$32K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Patience David made?
Patience David has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Patience David trade?
Patience David has filed SEC Form 4 disclosures for 1 company, including TLSI.
When was Patience David's most recent SEC Form 4 filing?
Patience David's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.
What is Patience David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Patience David is listed as Chief Financial Officer.
What is Patience David's total buy and sell value in the current window?
Inside the rolling retention window, Patience David bought $32K and sold $0 based on SEC Form 4 filings.
What was Patience David's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 7,100 TLSI shares on 2026-05-15, worth $17K, per SEC Form 4 filings.